Bismuth Potassium Citrate Capsules

This product is a gastric mucosal protective agent. Under gastric acid conditions, it forms a diffuse protective layer covering the ulcer surface, preventing gastric acid, enzymes and food from invading the ulcer, and promoting the regeneration of the ulcer mucosa and the healing of the ulcer. This product also has the effects of reducing the activity of pepsin, increasing mucin secretion, and promoting the release of PGE2 from the mucosa, thereby protecting the gastric mucosa. In addition, this product has a killing effect on Helicobacter pylori (Hp), thus promoting the healing of gastritis.

Bismuth Potassium Citrate

Gastric ulcer, duodenal ulcer, erythematous exudative gastritis, and erosive gastritis.

Oral administration. 4 times a day, 0.3g each time, the first 3 times half an hour before meals, the 4th time before bedtime with warm water, avoid carbonated beverages (such as beer). Do not drink milk or take antacids and other alkaline drugs half an hour before and after taking the medicine. The course of treatment is 4-8 weeks, then stop taking bismuth-containing drugs for 4-8 weeks, and continue taking it for another 4-8 weeks if necessary.

This drug is relatively safe at regular doses and within the cycle of use, but general adverse reactions may also occur: 1. Digestive system: During the use of this drug, the mouth may have an ammonia smell, and the tongue coating and stool may be gray-black, which is easily confused with the symptoms of black stool; some patients may experience nausea, vomiting, loss of appetite, diarrhea, constipation and other symptoms when taking it. The above symptoms may disappear on their own after stopping the drug. 2. Nervous system: A few patients may experience mild headaches, dizziness, insomnia, etc., but they can be tolerated. 3. Others: Some patients may develop rashes. Long-term high-dose use may cause the following adverse reactions: 1. When the blood concentration is greater than 100ng/ml, it may cause bismuth encephalopathy; 2. Urinary system: Long-term use of this drug may cause renal toxicity; 3. Bones and muscles: Adverse reactions of bones often occur in different parts, which are related to excessive bismuth concentration in the bones. The most common is osteoarthritis related to bismuth encephalopathy, often with unilateral or bilateral shoulder pain as a precursor symptom.

1. It is contraindicated for those who are allergic to this drug. 2. It is contraindicated for pregnant and lactating women. 3. It is contraindicated for those with severe renal insufficiency.

Precautions for children: Please refer to [Precautions]. Precautions for pregnancy and lactation: Prevented to use for pregnant and lactating women. Precautions for the elderly: Please refer to [Contraindications] and [Precautions].

Do not take with antacids.

Keep in a dark place, sealed and stored in a dry place (10-30℃).

0.3 g (containing bismuth 110 mg)

36 months

Nanjing Cuccess Pharmaceutical Co., Ltd.

• Founded in:

  2002-03-20

• Address:

  No. 20, Xingang Avenue, Nanjing Economic and Technological Development Zone

• Tax NO.:

  913201926089285606

• Registered Funds:

  60 million yuan

• Website:

  Log in to view

• Email:

  Log in to view